https://k858inhibitor.com/a-de....tailed-analysis-of-t
We evaluated the concordance among gene mutations tested by both G360 and F1 among three kinds of patients untreated, addressed without, and managed with EGFR inhibitors, while deciding the clonal and/or subclonal nature of each genomic alteration. OUTCOMES there clearly was a higher rate of concordance in APC, TP53, KRAS, NRAS, and BRAF mutations within the treatment-naive and non-anti-EGFR-treated cohorts. There was increased discordance within the anti-EGFR addressed patients in
Like
Comment
Share
